| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.6M | — | -5.0% |
| Cost of Revenue | $12.5M | — | -12.1% |
| Gross Profit | $32.1M | — | -1.9% |
| R&D Expense | $10.7M | — | -11.2% |
| SG&A Expense | $10.7M | — | +4.3% |
| Operating Income | -$1.2M | — | +22.4% |
| Pre-tax Income | -$1.3M | — | -679.2% |
| Income Tax | $2.5M | — | +82.9% |
| Net Income | -$3.8M | — | -236.8% |
| EPS (Basic) | -$0.03 | — | -200.0% |
| EPS (Diluted) | -$0.03 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $58.4M | +112.2% | +84.2% |
| Short-term Investments | $3.4M | -86.0% | -89.1% |
| Accounts Receivable | $17.1M | +4.2% | -6.3% |
| Current Assets | $98.6M | +8.7% | -2.8% |
| Total Assets | $159.8M | -3.0% | -7.5% |
| Current Liabilities | $122.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $656K | — | +162.7% |
| Capital Expenditures | $61K | — | -79.5% |
| Investing Cash Flow | $31.4M | — | +1299.3% |
| Financing Cash Flow | -$1.2M | — | +55.3% |
| Free Cash Flow | $595K | — | +144.3% |
| +27.7% |
| Long-term Debt | $27.8M | -5.1% | -12.9% |
| Total Liabilities | $155.1M | -2.0% | +3.3% |
| Stockholders' Equity | $4.6M | -26.7% | -79.5% |